{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-28",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 100048
    }
  },
  "results": [
    {
      "safetyreportversion": "4",
      "safetyreportid": "10004135",
      "primarysourcecountry": "US",
      "occurcountry": "US",
      "transmissiondateformat": "102",
      "transmissiondate": "20150821",
      "reporttype": "1",
      "serious": "2",
      "receivedateformat": "102",
      "receivedate": "20140312",
      "receiptdateformat": "102",
      "receiptdate": "20150525",
      "fulfillexpeditecriteria": "2",
      "companynumb": "US-JNJFOC-20140303748",
      "duplicate": "1",
      "reportduplicate": {
        "duplicatesource": "JANSSEN",
        "duplicatenumb": "US-JNJFOC-20140303748"
      },
      "primarysource": {
        "reportercountry": "US",
        "qualification": "3"
      },
      "sender": {
        "sendertype": "2",
        "senderorganization": "FDA-Public Use"
      },
      "receiver": {
        "receivertype": "6",
        "receiverorganization": "FDA"
      },
      "patient": {
        "patientonsetage": "45",
        "patientonsetageunit": "801",
        "patientagegroup": "5",
        "patientsex": "1",
        "reaction": [
          {
            "reactionmeddraversionpt": "18.0",
            "reactionmeddrapt": "Drug eruption",
            "reactionoutcome": "1"
          }
        ],
        "drug": [
          {
            "drugcharacterization": "1",
            "medicinalproduct": "STELARA",
            "drugbatchnumb": "DIS36MB",
            "drugstructuredosagenumb": "90",
            "drugstructuredosageunit": "003",
            "drugdosageform": "SOLUTION FOR INJECTION",
            "drugadministrationroute": "058",
            "drugindication": "PSORIASIS",
            "drugstartdateformat": "102",
            "drugstartdate": "20140304",
            "actiondrug": "1",
            "drugrecurreadministration": "2",
            "activesubstance": {
              "activesubstancename": "USTEKINUMAB"
            },
            "openfda": {
              "application_number": [
                "BLA761044",
                "BLA125261"
              ],
              "brand_name": [
                "STELARA"
              ],
              "generic_name": [
                "USTEKINUMAB"
              ],
              "manufacturer_name": [
                "Janssen Biotech, Inc."
              ],
              "product_ndc": [
                "57894-054",
                "57894-061",
                "57894-060"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "INTRAVENOUS",
                "SUBCUTANEOUS"
              ],
              "substance_name": [
                "USTEKINUMAB"
              ],
              "rxcui": [
                "853350",
                "853354",
                "853355",
                "853356",
                "1654077",
                "1654079",
                "1811255",
                "1811257"
              ],
              "spl_id": [
                "ff62ab2e-9413-4e22-95ad-74b582c14dc6"
              ],
              "spl_set_id": [
                "c77a9664-e3bb-4023-b400-127aa53bca2b"
              ],
              "package_ndc": [
                "57894-061-02",
                "57894-061-03",
                "57894-061-04",
                "57894-054-27",
                "57894-054-16",
                "57894-060-02",
                "57894-060-03",
                "57894-060-04"
              ],
              "nui": [
                "N0000192797",
                "N0000192796",
                "N0000192799",
                "N0000192798"
              ],
              "pharm_class_epc": [
                "Interleukin-12 Antagonist [EPC]",
                "Interleukin-23 Antagonist [EPC]"
              ],
              "pharm_class_moa": [
                "Interleukin-12 Antagonists [MoA]",
                "Interleukin-23 Antagonists [MoA]"
              ],
              "unii": [
                "FU77B4U5Z0"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "REMERON",
            "drugdosageform": "UNSPECIFIED",
            "drugadministrationroute": "065",
            "activesubstance": {
              "activesubstancename": "MIRTAZAPINE"
            },
            "openfda": {
              "application_number": [
                "NDA020415"
              ],
              "brand_name": [
                "REMERON"
              ],
              "generic_name": [
                "MIRTAZAPINE"
              ],
              "manufacturer_name": [
                "Organon LLC"
              ],
              "product_ndc": [
                "78206-160",
                "78206-161",
                "78206-156",
                "78206-158",
                "78206-159"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "MIRTAZAPINE"
              ],
              "rxcui": [
                "211322",
                "211323",
                "283406",
                "283407",
                "283485",
                "311725",
                "314111",
                "752869",
                "752870",
                "752871"
              ],
              "spl_id": [
                "8b121c7c-9bcd-4504-b789-3f551a0fe514"
              ],
              "spl_set_id": [
                "98ad1917-a094-44f5-a28f-a64a8cfcd887"
              ],
              "package_ndc": [
                "78206-160-01",
                "78206-161-01",
                "78206-156-99",
                "78206-156-01",
                "78206-158-99",
                "78206-158-01",
                "78206-159-99",
                "78206-159-01"
              ],
              "unii": [
                "A051Q2099Q"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "PRISTIQ EXTENDED RELEASE",
            "drugdosageform": "UNKNOWN",
            "drugadministrationroute": "065",
            "activesubstance": {
              "activesubstancename": "DESVENLAFAXINE SUCCINATE"
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "LITHIUM ASPARTATE",
            "drugdosageform": "UNSPECIFIED",
            "drugadministrationroute": "065",
            "activesubstance": {
              "activesubstancename": "LITHIUM ASPARTATE"
            }
          },
          {
            "drugcharacterization": "1",
            "medicinalproduct": "STELARA",
            "drugbatchnumb": "DIS36MB",
            "drugauthorizationnumb": "125261",
            "drugstructuredosagenumb": "90",
            "drugstructuredosageunit": "003",
            "drugdosageform": "SOLUTION FOR INJECTION",
            "drugadministrationroute": "058",
            "drugindication": "PSORIASIS",
            "drugstartdateformat": "102",
            "drugstartdate": "20131010",
            "drugenddateformat": "102",
            "drugenddate": "20140218",
            "actiondrug": "1",
            "drugrecurreadministration": "2",
            "activesubstance": {
              "activesubstancename": "USTEKINUMAB"
            },
            "openfda": {
              "application_number": [
                "BLA761044",
                "BLA125261"
              ],
              "brand_name": [
                "STELARA"
              ],
              "generic_name": [
                "USTEKINUMAB"
              ],
              "manufacturer_name": [
                "Janssen Biotech, Inc."
              ],
              "product_ndc": [
                "57894-054",
                "57894-061",
                "57894-060"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "INTRAVENOUS",
                "SUBCUTANEOUS"
              ],
              "substance_name": [
                "USTEKINUMAB"
              ],
              "rxcui": [
                "853350",
                "853354",
                "853355",
                "853356",
                "1654077",
                "1654079",
                "1811255",
                "1811257"
              ],
              "spl_id": [
                "ff62ab2e-9413-4e22-95ad-74b582c14dc6"
              ],
              "spl_set_id": [
                "c77a9664-e3bb-4023-b400-127aa53bca2b"
              ],
              "package_ndc": [
                "57894-061-02",
                "57894-061-03",
                "57894-061-04",
                "57894-054-27",
                "57894-054-16",
                "57894-060-02",
                "57894-060-03",
                "57894-060-04"
              ],
              "nui": [
                "N0000192797",
                "N0000192796",
                "N0000192799",
                "N0000192798"
              ],
              "pharm_class_epc": [
                "Interleukin-12 Antagonist [EPC]",
                "Interleukin-23 Antagonist [EPC]"
              ],
              "pharm_class_moa": [
                "Interleukin-12 Antagonists [MoA]",
                "Interleukin-23 Antagonists [MoA]"
              ],
              "unii": [
                "FU77B4U5Z0"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "VALIUM",
            "drugdosageform": "UNSPECIFIED",
            "drugadministrationroute": "065",
            "activesubstance": {
              "activesubstancename": "DIAZEPAM"
            },
            "openfda": {
              "application_number": [
                "NDA013263"
              ],
              "brand_name": [
                "VALIUM"
              ],
              "generic_name": [
                "DIAZEPAM"
              ],
              "manufacturer_name": [
                "Roche Laboratories Inc."
              ],
              "product_ndc": [
                "0140-0004",
                "0140-0005"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "DIAZEPAM"
              ],
              "rxcui": [
                "104699",
                "104700",
                "197590",
                "197591"
              ],
              "spl_id": [
                "ea505cdb-6d89-4b8c-8007-ec5a5fe920ce"
              ],
              "spl_set_id": [
                "554baee5-b171-4452-a50a-41a0946f956c"
              ],
              "package_ndc": [
                "0140-0004-01",
                "0140-0005-01",
                "0140-0005-14"
              ],
              "nui": [
                "N0000175694",
                "M0002356"
              ],
              "pharm_class_epc": [
                "Benzodiazepine [EPC]"
              ],
              "pharm_class_cs": [
                "Benzodiazepines [CS]"
              ],
              "unii": [
                "Q3JTX2Q7TU"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "WELLBUTRIN",
            "drugdosageform": "UNSPECIFIED",
            "drugadministrationroute": "065",
            "activesubstance": {
              "activesubstancename": "BUPROPION HYDROCHLORIDE"
            },
            "openfda": {
              "application_number": [
                "NDA021515",
                "NDA020358"
              ],
              "brand_name": [
                "WELLBUTRIN XL",
                "WELLBUTRIN SR"
              ],
              "generic_name": [
                "BUPROPION HYDROCHLORIDE"
              ],
              "manufacturer_name": [
                "Bausch Health US LLC",
                "GlaxoSmithKline LLC"
              ],
              "product_ndc": [
                "0187-0730",
                "0187-0731",
                "0173-0135",
                "0173-0947",
                "0173-0722"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "BUPROPION HYDROCHLORIDE"
              ],
              "rxcui": [
                "993541",
                "993545",
                "993557",
                "993564",
                "993503",
                "993511",
                "993518",
                "993528",
                "993536",
                "993537"
              ],
              "spl_id": [
                "22308f71-fc56-430d-b559-bed47e17a46c",
                "5ffc8b63-7d69-4f3a-bf05-a9c138724a91"
              ],
              "spl_set_id": [
                "a435da9d-f6e8-4ddc-897d-8cd2bf777b21",
                "cbc8c074-f080-4489-a5ae-207b5fadeba3"
              ],
              "package_ndc": [
                "0187-0730-30",
                "0187-0730-90",
                "0187-0730-07",
                "0187-0731-30",
                "0187-0731-07",
                "0173-0947-55",
                "0173-0135-55",
                "0173-0722-00"
              ],
              "unii": [
                "ZG7E5POY8O"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "GEODON",
            "drugdosageform": "UNKNOWN",
            "drugadministrationroute": "065",
            "activesubstance": {
              "activesubstancename": "ZIPRASIDONE HYDROCHLORIDE\\ZIPRASIDONE MESYLATE"
            },
            "openfda": {
              "application_number": [
                "NDA020825",
                "NDA020919"
              ],
              "brand_name": [
                "GEODON"
              ],
              "generic_name": [
                "ZIPRASIDONE",
                "ZIPRASIDONE MESYLATE",
                "ZIPRASIDONE HYDROCHLORIDE"
              ],
              "manufacturer_name": [
                "Viatris Specialty LLC",
                "ROERIG"
              ],
              "product_ndc": [
                "58151-131",
                "58151-132",
                "58151-133",
                "58151-134",
                "58151-137",
                "0049-0056",
                "0049-3960",
                "0049-3980",
                "0049-3990",
                "0049-3920",
                "0049-0052",
                "0049-0054",
                "0049-0058",
                "0049-0352",
                "0049-0354",
                "0049-0356",
                "0049-0358"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL",
                "INTRAMUSCULAR"
              ],
              "substance_name": [
                "ZIPRASIDONE",
                "ZIPRASIDONE MESYLATE",
                "ZIPRASIDONE HYDROCHLORIDE"
              ],
              "rxcui": [
                "284548",
                "284549",
                "284550",
                "285127",
                "313776",
                "313777",
                "313778",
                "314286",
                "351223",
                "352228"
              ],
              "spl_id": [
                "8351d3a9-c9f8-4ae0-be80-ae3a4ef02820",
                "c717f8ab-3351-4caa-b1fa-86c2fa415189"
              ],
              "spl_set_id": [
                "a2b4cc65-6a6d-49c4-adfc-a4458562a167",
                "8326928a-2cb6-4f7f-9712-03a425a14c37"
              ],
              "package_ndc": [
                "58151-131-91",
                "58151-132-91",
                "58151-133-91",
                "58151-134-91",
                "58151-137-81",
                "0049-3960-60",
                "0049-3980-60",
                "0049-3990-60",
                "0049-3920-20",
                "0049-3920-83",
                "0049-3920-01",
                "0049-3920-10",
                "0049-0052-60",
                "0049-0054-60",
                "0049-0056-60",
                "0049-0058-60",
                "0049-0352-60",
                "0049-0354-60",
                "0049-0356-60",
                "0049-0358-60"
              ],
              "nui": [
                "N0000175430"
              ],
              "pharm_class_epc": [
                "Atypical Antipsychotic [EPC]"
              ],
              "unii": [
                "6UKA5VEJ6X",
                "3X6SAX83JZ",
                "216X081ORU"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "DEPAKOTE",
            "drugdosageform": "UNSPECIFIED",
            "drugadministrationroute": "065",
            "activesubstance": {
              "activesubstancename": "DIVALPROEX SODIUM"
            },
            "openfda": {
              "application_number": [
                "NDA021168",
                "NDA018723",
                "NDA019680"
              ],
              "brand_name": [
                "DEPAKOTE ER",
                "DEPAKOTE",
                "DEPAKOTE SPRINKLES"
              ],
              "generic_name": [
                "DIVALPROEX SODIUM"
              ],
              "manufacturer_name": [
                "AbbVie Inc."
              ],
              "product_ndc": [
                "0074-7401",
                "0074-3826",
                "0074-7126",
                "0074-7402",
                "0074-7325",
                "0074-6212",
                "0074-6214",
                "0074-6215",
                "0074-7327",
                "0074-7326",
                "0074-6114"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "DIVALPROEX SODIUM"
              ],
              "rxcui": [
                "1099563",
                "1099565",
                "1099569",
                "1099571",
                "1099625",
                "1099626",
                "1099678",
                "1099679",
                "1099870",
                "1099871",
                "1099596",
                "1099598"
              ],
              "spl_id": [
                "0ee65b66-ead3-44ef-911f-14965b067903",
                "7cc3a0b3-93f8-4825-88e1-bf6ddb0db23d",
                "d038b7e9-b014-4771-93be-90aeeaece03d"
              ],
              "spl_set_id": [
                "0dc024ce-efc8-4690-7cb5-639c728fccac",
                "08a65cf4-7749-4ceb-6895-8f4805e2b01f",
                "4619aff4-0f80-444f-858d-42e4137aa809"
              ],
              "package_ndc": [
                "0074-3826-13",
                "0074-3826-11",
                "0074-7401-13",
                "0074-7126-13",
                "0074-7126-53",
                "0074-7126-11",
                "0074-7126-72",
                "0074-7402-13",
                "0074-6212-13",
                "0074-6214-13",
                "0074-6214-53",
                "0074-6215-13",
                "0074-6215-53",
                "0074-7325-13",
                "0074-7327-13",
                "0074-7326-13",
                "0074-6114-13",
                "0074-6114-11"
              ],
              "unii": [
                "644VL95AO6"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "TRAZODONE",
            "drugdosageform": "UNSPECIFIED",
            "drugadministrationroute": "065",
            "activesubstance": {
              "activesubstancename": "TRAZODONE HYDROCHLORIDE"
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "DEXEDRINE",
            "drugdosageform": "UNSPECIFIED",
            "drugadministrationroute": "065",
            "activesubstance": {
              "activesubstancename": "DEXTROAMPHETAMINE SULFATE"
            },
            "openfda": {
              "application_number": [
                "NDA017078"
              ],
              "brand_name": [
                "DEXEDRINE SPANSULE"
              ],
              "generic_name": [
                "DEXTROAMPHETAMINE SULFATE"
              ],
              "manufacturer_name": [
                "Amneal Pharmaceuticals LLC"
              ],
              "product_ndc": [
                "64896-673",
                "64896-674",
                "64896-675"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "DEXTROAMPHETAMINE SULFATE"
              ],
              "rxcui": [
                "884520",
                "884528",
                "884532",
                "884534",
                "884535",
                "884537"
              ],
              "spl_id": [
                "d5d5a976-872f-4849-b222-1fb433511511"
              ],
              "spl_set_id": [
                "cc717b9b-22ea-4c60-a1d4-ee38a40bce78"
              ],
              "package_ndc": [
                "64896-673-10",
                "64896-674-10",
                "64896-675-10"
              ],
              "unii": [
                "JJ768O327N"
              ]
            }
          }
        ],
        "summary": {
          "narrativeincludeclinical": "CASE EVENT DATE: 20140304"
        }
      }
    }
  ]
}